Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexamethasone for prevention of postoperative nausea and vomiting after elective cesarean section
IRCT20190409043219N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in postoperative nausea and vomiting (PONV), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Aug 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190409043219N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190409043219N2.